Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy-Reference-Cited by-同舟云学术

Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy

Published:2006-11-13 Issue:18 Volume:26 Page:2563-2573
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Yuan L,Siegel M,Choi K,Khosla C,Miller C R,Jackson E N,Piwnica-Worms D,Rich K M

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1210048.pdf

Reference30 articles.

1. Aeschlimann D, Thomazy V . (2000). Protein cross-linking in assembly and remodeling of extracellular matrices: the role of transglutaminases. Connect Tissue Res 41: 1–27.

2. Akimov SS, Belkin AM . (2001). Cell-surface transglutaminase promotes fibronectin assembly via interaction with the gelatin-binding domain of fibronectin: a role in TGFbeta-dependent matrix deposition. J Cell Sci 114: 2989–3000.

3. Akimov SS, Krylov D, Fleischman LF, Belkin AM . (2000). Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Bio 148: 825–838.

4. Buckley CD, Pilling D, Henriquez NV, Parsonage G, Threlfall K, Scheel-Toellner D et al. (1999). RGD peptides induce apoptosis by direct caspase-3 activation. Nature 397: 534–539.

5. Castellani P, Borsi L, Carnemolla B, Biro A, Dorcaratto A, Viale GL et al. (2002). Differentiation between high- and low-grade astrocytoma using a human recombinant antibody to the extra domain-B of fibronectin. Am J Pathol 161: 1695–1700.

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct conformational states enable transglutaminase 2 to promote cancer cell survival versus cell death;Communications Biology;2024-08-13

2. Biological Implications and Functional Significance of Transglutaminase Type 2 in Nervous System Tumors;Cells;2024-04-11

3. Pathogenetic Contributions and Therapeutic Implications of Transglutaminase 2 in Neurodegenerative Diseases;International Journal of Molecular Sciences;2024-02-17

4. Defining the conformational states that enable transglutaminase 2 to promote cancer cell survival versus cell death;2024-02-08

5. Tissue transglutaminase: a multifunctional and multisite regulator in health and disease;Physiological Reviews;2024-01-01